We are live on ! Find out more
IDXX icon

Idexx Laboratories

1,059 hedge funds and large institutions have $32.4B invested in Idexx Laboratories in 2023 Q3 according to their latest regulatory filings, with 89 funds opening new positions, 385 increasing their positions, 386 reducing their positions, and 86 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.1% more ownership

Funds ownership: 88.06%89.16% (+1.1%)

3% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 86

0% less repeat investments, than reductions

Existing positions increased: 385 | Existing positions reduced: 386

1% less funds holding

Funds holding: 1,0681,059 (-9)

12% less capital invested

Capital invested by funds: $36.7B → $32.4B (-$4.33B)

16% less funds holding in top 10

Funds holding in top 10: 2521 (-4)

18% less call options, than puts

Call options by funds: $86.1M | Put options by funds: $105M

Holders
1,059
Holders Change
-9
Holders Change %
-0.84%
% of All Funds
16.81%
Holding in Top 10
21
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-16%
% of All Funds
0.33%
New
89
Increased
385
Reduced
386
Closed
86
Calls
$86.1M
Puts
$105M
Net Calls
-$18.9M
Net Calls Change
-$56M
Name Holding Trade Value Shares
Change
Change in
Stake
RWA
401
Ropes Wealth Advisors
Massachusetts
$2.39M -$821K -1,646 -23%
SIS
402
Strategic Investment Solutions
Illinois
$2.39M +$2.35M +4,712 +6,200%
MGIA
403
Moneta Group Investment Advisors
Missouri
$2.37M -$332K -666 -11%
Cetera Investment Advisers
404
Cetera Investment Advisers
Illinois
$2.36M
EI
405
Ethic Inc
New York
$2.36M +$77.8K +156 +3%
CRC
406
Curi RMB Capital
Illinois
$2.33M -$54.9K -110 -2%
CGH
407
Crossmark Global Holdings
Texas
$2.28M +$231K +463 +10%
CAM
408
Congress Asset Management
Massachusetts
$2.28M -$177K -355 -6%
DC
409
Davenport & Co
Virginia
$2.28M -$84.3K -169 -3%
EWM
410
Evercore Wealth Management
New York
$2.27M -$178K -357 -6%
AWS
411
Atria Wealth Solutions
New York
$2.25M +$7.48K +15 +0.3%
Vontobel Holding
412
Vontobel Holding
Switzerland
$2.23M +$258K +517 +11%
NA
413
NewEdge Advisors
Louisiana
$2.23M +$556K +1,114 +28%
Acadian Asset Management
414
Acadian Asset Management
Massachusetts
$2.22M -$544K -1,090 -18%
Cerity Partners
415
Cerity Partners
New York
$2.21M -$2.16M -4,340 -46%
CAM
416
Cresset Asset Management
Illinois
$2.2M +$65.3K +131 +3%
MGP
417
Metis Global Partners
California
$2.19M +$535K +1,072 +27%
KA
418
Kintegral Advisory
New York
$2.19M -$1.5K -3 -0.1%
MAM
419
Montanaro Asset Management
United Kingdom
$2.19M -$5.24M -10,500 -68%
BOSSRA
420
B.O.S.S. Retirement Advisors
Utah
$2.17M +$100K +201 +4%
LAI
421
Legal Advantage Investments
California
$2.17M +$180K +360 +8%
SLI
422
Sumitomo Life Insurance
Japan
$2.13M +$92.3K +185 +4%
Luther King Capital Management (LKCM)
423
Luther King Capital Management (LKCM)
Texas
$2.12M -$4.99K -10 -0.2%
CGIM
424
Capital Group Investment Management
Singapore
$2.12M
MF
425
Magnetar Financial
Illinois
$2.07M +$2.37M +4,745 New

IDXX Hedge Fund Activity: Q3 2023 in Review

1,059 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2023, worth a combined $32.4B — down 12% from $36.7B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new IDXX positions and 86 closed out — a net gain of 3 holders — while 385 added to existing stakes and 386 trimmed.

The largest buyer was GQG Partners, opening a new position worth an estimated $465M. The largest seller was AllianceBernstein, cutting an estimated $133M.

  • 1,059 institutional investors held Idexx Laboratories (IDXX) as of Q3 2023, down from 1,068 in Q2 2023.
  • Funds reported $32.4B of Idexx Laboratories stock for Q3 2023, down 12% quarter-over-quarter.
  • 89 funds opened new Idexx Laboratories positions in Q3 2023 and 86 closed out, a net change of +3 holders.
  • The largest Idexx Laboratories buyer in Q3 2023 was GQG Partners, an estimated $465M added.
  • The largest Idexx Laboratories seller in Q3 2023 was AllianceBernstein, an estimated $133M sold.

Based on aggregated 13F filings for Q3 2023.